Wang SE - Search Results

1

H1047R phosphatidylinositol 3-kinase mutant enhances HER2-mediated transformation by heregulin production and activation of HER3.

Chakrabarty A, Rexer BN, Wang SE, Cook RS, Engelman JA, Arteaga CL. Chakrabarty A, et al. Among authors: wang se. Oncogene. 2010 Sep 16;29(37):5193-203. doi: 10.1038/onc.2010.257. Epub 2010 Jun 28. Oncogene. 2010. PMID: 20581867 Free PMC article.

2

Oncogenic mutations regulate tumor microenvironment through induction of growth factors and angiogenic mediators.

Wang SE, Yu Y, Criswell TL, Debusk LM, Lin PC, Zent R, Johnson DH, Ren X, Arteaga CL. Wang SE, et al. Oncogene. 2010 Jun 10;29(23):3335-48. doi: 10.1038/onc.2010.112. Epub 2010 Apr 12. Oncogene. 2010. PMID: 20383197 Free PMC article.

3

Overexpression of HER2 (erbB2) in human breast epithelial cells unmasks transforming growth factor beta-induced cell motility.

Ueda Y, Wang S, Dumont N, Yi JY, Koh Y, Arteaga CL. Ueda Y, et al. J Biol Chem. 2004 Jun 4;279(23):24505-13. doi: 10.1074/jbc.M400081200. Epub 2004 Mar 24. J Biol Chem. 2004. PMID: 15044465 Free article.

4

Transforming growth factor {beta} (TGF-{beta})-Smad target gene protein tyrosine phosphatase receptor type kappa is required for TGF-{beta} function.

Wang SE, Wu FY, Shin I, Qu S, Arteaga CL. Wang SE, et al. Mol Cell Biol. 2005 Jun;25(11):4703-15. doi: 10.1128/MCB.25.11.4703-4715.2005. Mol Cell Biol. 2005. PMID: 15899872 Free PMC article.

5

HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors.

Wang SE, Narasanna A, Perez-Torres M, Xiang B, Wu FY, Yang S, Carpenter G, Gazdar AF, Muthuswamy SK, Arteaga CL. Wang SE, et al. Cancer Cell. 2006 Jul;10(1):25-38. doi: 10.1016/j.ccr.2006.05.023. Cancer Cell. 2006. PMID: 16843263 Free article.

6

HER2/Neu (ErbB2) signaling to Rac1-Pak1 is temporally and spatially modulated by transforming growth factor beta.

Wang SE, Shin I, Wu FY, Friedman DB, Arteaga CL. Wang SE, et al. Cancer Res. 2006 Oct 1;66(19):9591-600. doi: 10.1158/0008-5472.CAN-06-2071. Cancer Res. 2006. PMID: 17018616

7

Convergence of p53 and transforming growth factor beta (TGFbeta) signaling on activating expression of the tumor suppressor gene maspin in mammary epithelial cells.

Wang SE, Narasanna A, Whitell CW, Wu FY, Friedman DB, Arteaga CL. Wang SE, et al. J Biol Chem. 2007 Feb 23;282(8):5661-9. doi: 10.1074/jbc.M608499200. Epub 2007 Jan 4. J Biol Chem. 2007. PMID: 17204482 Free PMC article.

8

relocating job wise? A mathematical model separates quantitatively the cytostatic and cytotoxic effects of a HER2 tyrosine kinase inhibitor.

Hinow P, Wang SE, Arteaga CL, Webb GF. Hinow P, et al. Among authors: wang se. Theor Biol Med Model. 2007 Apr 3;4:14. doi: 10.1186/1742-4682-4-14. Theor Biol Med Model. 2007. PMID: 17407594 Free PMC article.

9

Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins.

Guix M, Faber AC, Wang SE, Olivares MG, Song Y, Qu S, Rinehart C, Seidel B, Yee D, Arteaga CL, Engelman JA. Guix M, et al. Among authors: wang se. J Clin Invest. 2008 Jul;118(7):2609-19. doi: 10.1172/JCI34588. J Clin Invest. 2008. PMID: 18568074 Free PMC article.

10

Transforming growth factor beta engages TACE and ErbB3 to activate phosphatidylinositol-3 kinase/Akt in ErbB2-overexpressing breast cancer and desensitizes cells to trastuzumab.

Wang SE, Xiang B, Guix M, Olivares MG, Parker J, Chung CH, Pandiella A, Arteaga CL. Wang SE, et al. Mol Cell Biol. 2008 Sep;28(18):5605-20. doi: 10.1128/MCB.00787-08. Epub 2008 Jul 14. Mol Cell Biol. 2008. PMID: 18625725 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

309 results

Search Page

Filters